Comparative analysis of the activity and content of different streptokinase preparations

European Heart Journal

Volumn 26, Issue 9, 2005, Pages 933-940

  Hermentin, Peter ^a   Cuesta Linker, Thomas ^a   Weisse, Joerg ^a   Schmidt, Karl Heinz ^a   Knorst, Marion ^a   Scheld, Michael ^a   Thimme, Michael ^a  

^a ZLB Behring GmbH   (Germany)

Author keywords

Infarction; Protein sequence; Streptokinase; Thrombolysis

Indexed keywords

AKINASE; CHROMOGENIC SUBSTRATE; DURAKINASE; ESKINASE; FIBRINOLYTIC AGENT; HEBERKINASE; ICIKINASE; RECOMBINANT STREPTOKINASE; SOLUSTREP; STREK; STREPTOKINASE; STREPTONASE; THROMBOSOLV; TREPTASE; UNCLASSIFIED DRUG; UNITINASE;

AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG PURITY; ENZYME ACTIVITY; ENZYME SUBSTRATE; MEDICAL LITERATURE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

ELECTROPHORESIS, POLYACRYLAMIDE GEL; FIBRINOLYTIC AGENTS; HUMANS; RECOMBINANT PROTEINS; STREPTOKINASE; THERAPEUTIC EQUIVALENCY;

EID: 18744376598     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi093     Document Type: Article

References (19)

1. Tillet WS, Garner RL. The fibrinolytic activity of hemolytic streptococci. J Exp Med 1933;58:485-502.
2. Gross R, Hartl W, Kloss G et al. [Thrombolysis by infusions of highly purified streptokinase. Experience and research on the first 50 patients]. Dtsch Med Wochenschr 1960;85:2129-2141.
3. Sherry S, Fletcher AP, Alkjaersig N. Fibrinolysis and fibrinolytic activity in man. Physiol Rev 1959;39:343-382.
4. Boersma E, Mercado N, Poldermans D et al. Acute myocardial infarction. Lancet 2003;361:847-858.
5. World Health Organization. The WHO Model List of Essential Medicines. 7 October 2003, http://www.who.int/medicines/organization/par/edl/expcom13/ eml13_en.pdf (15 October 2003)
6. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:311-322.
7. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1:397-402.
8. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988;2:349-360.
9. Yusuf S, Collins R, Peto R et al. Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. Eur Heart J 1985;6:556-585.
10. Parmley WW. Cost-effectiveness of reperfusion strategies. Am Heart J 1999;138:S142-152.
11. Gillis JC, Goa KL. Streptokinase. A pharmacoeconomic appraisal of its use in the management of acute myocardial infarction. Pharmacoeconomics 1996;10:281-310.
12. Cannon CP. Exploring the issues of appropriate dosing in the treatment of acute myocardial infarction: potential benefits of bolus fibrinolytic agents. Am Heart J 2000;140(Suppl.):S154-160.
13. GUSTO investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-682.
14. Vorchheimer DA, Baruch L, Thompson TD. North American vs non-North American streptokinase use in GUSTO-1: impact of protocol deviation on mortality benefit of TPA (Abstract). Circulation 1997;96(Suppl.1):1-535.
15. Ryan TJ, Anderson JL, Antman EM et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 1996;28:1328-1428.
16. European Society of Cardiology. Acute myocardial infarction: pre-hospital and in-hospital management. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 1996;17:43-63.
17. European Directorate for the Quality of Medicines - Council of Europe. European Pharmacopoeia. 4th Edition. Strasbourg: EDCM; 2002.
18. Huang TT, Malke H, Ferretti JJ. The streptokinase gene of group A streptococci: cloning, expression in Escherichia coli, and sequence analysis. Mol Microbiol 1989;3:197-205.
19. Ohkuni H, Todome Y, Suzuki H et al. Immunochemical studies and complete amino acid sequence of the streptokinase from Streptococcus pyogenes (group A) M typ. 12 strain A374. Infect Immun 1992;60:278-283.